Blog
RSS FeedPosted by Michael Wonder on 10 Dec 2019
Pharmacare with no new medicines
10 December 2019 - Meeting with pricing officials shows that government's true goal is to slash prices so low that no ...
Posted by Michael Wonder on 10 Dec 2019
Do large pharma companies provide drug development innovation? Our analysis says no.
10 December 2019 - Large pharmaceutical companies oppose legislation being considered by Congress to lower the prices of prescription drugs. ...
Posted by Michael Wonder on 06 Dec 2019
Proposed changes to research and development tax incentive will discourage investment and undermine innovation
6 December 2019 - Medicines Australia is disappointed that proposed changes to the Research and Development Tax Incentive were tabled ...
Posted by Michael Wonder on 04 Dec 2019
White House claims Speaker Nancy Pelosi’s drug pricing bill would result in 100 fewer drugs over a decade
3 December 2019 - The report from the administration suggests far greater consequences for both the drug industry and American consumers ...
Posted by Michael Wonder on 26 Nov 2019
Using GRADE methodology to assess innovation of new medicinal products in Italy
25 November 2019 - In April 2017 the Italian Medicine Agency developed new criteria to grant any new medicinal product with ...
Posted by Michael Wonder on 17 Oct 2019
Pelosi’s drug pricing plan puts medical innovation at risk
17 October 2019 - The future of medical innovation in America is at a crossroads. ...
Posted by Michael Wonder on 26 Jul 2019
Intellectual property law amends will add to business uncertainty
26 July 2019 - Medicines Australia supports efforts to strengthen Australia’s Intellectual Property arrangements to be consistent with international best ...
Posted by Michael Wonder on 22 Jul 2019
Government to invest £16 million in 'life-saving' medical advances
22 July 2019 - The Government has announced the decision to invest around £16 million in various ‘life-saving’ medical advances, ...
Posted by Michael Wonder on 14 Jul 2019
How the FDA uses science to speed medical device innovation
11 July 2019 - The MDDT program streamlines the medical device development and review process. ...
Posted by Michael Wonder on 09 Jul 2019
GSK welcomes the UK trial of subscription-style payment system for pharma companies to incentivise creation of new antibiotics
9 July 2019 - GSK is committed to tackling antimicrobial resistance as part of a sustained, multi-stakeholder response to this global ...
Posted by Michael Wonder on 09 Jul 2019
UK launches subscription style payment pilot to incentivise pharma antibiotics R&D
9 July 2019 - The UK is to try out a subscription-style payment model aimed at incentivising pharma and biotech ...
Posted by Michael Wonder on 02 Jul 2019
Innovation prizes to support cell and gene therapy
2 July 2019 - Personalised cell and gene therapy represent a fundamental therapeutic revolution. ...
Posted by Michael Wonder on 02 Jul 2019
Rebalancing high prescription drug prices with innovation incentive
1 July 2019 - The current firestorm over high drug prices didn’t start with the May 2019 approval of Novartis’s onasemnogene ...
Posted by Michael Wonder on 22 Jun 2019
Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D
21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs. ...
Posted by Michael Wonder on 20 Jun 2019
Sustainable discovery and development of antibiotics — is a non-profit approach the future?
19 June 2019 - Shifting to a nonprofit-driven model for development of antibiotics could encourage discovery and development of truly needed ...